Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by cleareyeon Jul 15, 2020 9:24am
98 Views
Post# 31269734

RE:RE:Core vs. COVID19

RE:RE:Core vs. COVID19Thanks Nomoreshells4me.

I a familiar with that new release. I hope that it works. I also hope that they don't take their eye off the ball in developing their pre-COVID19 business.

It is generous of Lattice Biologics to work on the COVID19 response, like any corporate or private individual. So, I don't criticize them for doing that. And, as I said, I wish them well. COVID19 will eventually be in our rearview mirror but the debts that many of us incur will remain. LBL will need that core business to grow, pay off debts and eventually reward shareholders.

Based on their core business, I believe that 5 cents is a very low share price.

cleareye.
<< Previous
Bullboard Posts
Next >>